Guidelines for the diagnosis and treatment of acquired pneumonia and ventilator-associated pneumonia in adult hospitals in China (2018 edition)

Issued by: Infectious diseases group, respiratory society, Chinese medical association

Post date: June 4, 2018

Brief introduction:

Hospital acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) are the most common hospital acquired infections in China. In 1999, China published the “guidelines for the diagnosis and treatment of hospital-acquired pneumonia (draft)”, which has been nearly 20 years. During this period, many VAP/HAP guidelines have been published and updated at home and abroad. With the deepening of relevant research, the definition of HAP/VAP is changing, and a large number of new research achievements have been accumulated in epidemiology, etiology, clinical diagnosis and treatment, etc., especially the increasing research evidence in China, which shows that the pathogen distribution and drug resistance rate of HAP/VAP in China are quite different from those in other countries. Therefore, the original guidelines need to be revised to better guide clinical practice.

The guidelines were revised by the infectious diseases group of the respiratory society of the Chinese medical association. After several on-site work meetings, the overall framework and main update contents of HAP/VAP were determined. On the basis of following the evidence of evidence-based medicine, after repeated discussion by all the members of the academic group, a unified opinion was formed, and the opinions of experts in related fields were widely solicited at home and abroad.

Classification: respiratory infection